<DOC>
	<DOCNO>NCT01736670</DOCNO>
	<brief_summary>Triamcinolone acetonide mid-potency , class 4/5 topical corticosteroid available spray formulation ( Triamcinolone Acetonide Spray , T Spray ) . It indicate relief inflammatory pruritic manifestation corticosteroid-responsive dermatosis . Unlike potent steroid product , T Spray time limitation use ; therefore , commonly use treat flare psoriasis , atopic dermatitis , seborrheic dermatitis , contact dermatitis . In contrast cream ointment , T Spray easily cover large hard-to-reach area body . Its optional nozzle directs application medication precise area without affect nearby area . Patients require mid-potency corticosteroid lesion scalp , back , intertriginous fold , large area , area require precise application would benefit T Spray formulation . In time since introduction T Spray dermatology , topical corticosteroid enter market , T Spray remain mid-potency corticosteroid available spray formulation . In recently publish open-label , non-comparator study involve 42 patient chronic steroid-responsive dermatosis , T Spray use four time day 28 day . Improvement lesion one week treatment experience 85 % patient , 95 % subject prefer spray creams ointment . Most importantly , 56 % patient report anti-pruritic cooling effect experience upon application .</brief_summary>
	<brief_title>An Investigator-Initiated Study Assess Cooling Effect Triamcinolone Acetonide Aerosol When Used Steroid-Responsive Dermatoses</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . Subjects must least 18 year old good general health , confirm medical history 2 . A clear diagnosis chronic steroidresponsive dermatosis ( i.e . psoriasis , atopic dermatitis ) acute steroidresponsive dermatosis ( i.e . contact dermatitis , firstdegree burn ) must previously establish patient must target lesion assessed severity inflammation 3 . Females childbearing potential must negative urine pregnancy test participate study 4 . Subjects must able understand requirement study sign inform consent prior study procedure 1 . Subjects pregnant and/or nursing 2 . Subjects know hypersensitivity component T Spray 3 . Subjects use medication disease judgment investigator interfere conduct interpretation study 4 . Subjects follow pathology : cold urticaria , cryoglobulinemia , Raynaud 's phenomenon , Paroxysmal cold hemoglobulinuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>